Pharmaceutical Companies Eye India
On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion.
5191
Three Trends That Will Impact Pharma’s Future
The future of the pharmaceutical industry depends on three key trends, says a recent editorial in the Harvard Business Review.